About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

TERMINATEDNCT00767234

Permission to Collect Blood Over Time for Research

To determine whether biomarkers assessed in blood samples can be used to detect individuals at risk for developing blood clots or worsening of their underlying disease. The ultimate goal of the study ...

Lead sponsor: Stanford University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Stanford University

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Male or female, \>= 18 years old. There are no ethnic restrictions.
•Active cancers of the GI tract (gastroesophageal, colorectal, or pancreatic-biliary) that have completed TNM staging by the American Joint Committee on Cancer; stage III disease if diagnosed within 2 months and all stage IV disease
•Ability to understand and the willingness to sign a written informed consent document.
•Existing staging CT imaging study

Exclusion Criteria

•Life expectancy \< 6 months
•History of deep vein thrombosis (DVT) or pulmonary embolism (PE)
•Known pregnancy or positive urine pregnancy test in pre-menopausal women
•On anticoagulant therapy (heparin, warfarin, direct thrombin inhibitors)
•No CT imaging studies, or contraindications to undergoing CT imaging
•Existing or anticipated need for a tunneled central venous catheter
•Clinic visitation to Stanford Cancer center for secondary consultation purposes only
•Inability to give informed consent

Related studies

Determining Minimal Residual Disease Using ctDNA Deep Sequencing

NCT07660627 · Esophageal Adenocarcinoma, Gastric Cancer, and more

RECRUITINGPhase 1

A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

NCT06663319 · Colorectal Neoplasms, Gastrointestinal Neoplasms

Indocyanine Green-Guided Versus Standard Laparoscopic Distal Pancreatectomy for Pancreatic Body and Tail Lesions

NCT07656571 · Pancreatic Neoplasms, Pancreatic Cancer

A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

NCT07651358 · Stage I Pancreatic Cancer AJCC v8, Stage II Pancreatic Cancer AJCC v8, and more

RECRUITINGEARLY Phase 1

Lidocaine Infusion in Pancreatic Cancer

NCT04048278 · Pancreatic Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 11, 2016Terms

Trial snapshot

StatusTERMINATED

Phase—

Enrollment104

Start dateAug 2008

Last updatedJul 11, 2016

Condition

Pancreatic Cancer Gastrointestinal Neoplasms Colon Rectal Cancer Adenocarcinoma Esophageal Cancer Gall Bladder Cancer+9 more

Locations shown

Stanford University School of Medicine

Stanford, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 11, 2016Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions